Selkoe, Dennis J
Hardy, John
Funding for this research was provided by:
National Institute on Aging (AG06173)
National Institute on Aging (AG015379)
MRC
ARUK
Wellcome Trust
Article History
Received: 11 January 2016
Revised: 24 February 2016
Accepted: 10 March 2016
First Online: 29 March 2016
Conflict of interest
: DS is a director of Prothena Biosciences and has received consulting fees from Janssen, Roche, and Sanofi and a speaker's fee from Biogen‐Idec. JH consults for Eisai and for Cytox and has received speaking fees from Eli Lilly, Takeda, and Roche.